Is HPV-DNA Testing a Useful Tool in Predicting Low-Grade Squamous Intraepithelial Lesion Outcome? A Retrospective Longitudinal Study

Strategies for Successful Vaccination against Hepatocellular Carcinoma

(2017) M. Rinaldi et al.   INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY

An Analysis of High-Risk Human Papillomavirus DNA-Negative Cervical Precancers in the ASCUS-LSIL Triage Study (ALTS)

(2010) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

Longitudinal Cytological Follow-up of Patients With a Papanicolaou Test Interpretation of "Atypical Squamous Cells of Undetermined Significance" That Was Followed by a Negative Reflex Test for High-Risk Human Papillomavirus Types

(2009) Rosemarie Rodriguez et al.   INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY

Human Papillomavirus in Cervical Cancer Screening: Important Role as Biomarker

(2008) G. A.V. Boulet et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Natural history and epidemiology of HPV infection and cervical cancer

(2008) Xavier Castellsagué   GYNECOLOGIC ONCOLOGY

Screening for Cervical Cancer in the Era of the HPV Vaccine--The Urgent Need for Both New Screening Guidelines and New Biomarkers

(2008) N. B. Kiviat et al.   JNCI-Journal of the National Cancer Institute

Rapid Clearance of Human Papillomavirus and Implications for Clinical Focus on Persistent Infections

(2008) A. C. Rodriguez et al.   JNCI-Journal of the National Cancer Institute

Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial

(2008) Francesca Carozzi et al.   LANCET ONCOLOGY